UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014175
Receipt number R000016510
Scientific Title ESSENSE protocol for peri-operative patients management; a multi-center prospective clinical trial
Date of disclosure of the study information 2014/06/15
Last modified on 2016/06/05 20:05:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

ESSENSE protocol for peri-operative patients management; a multi-center prospective clinical trial

Acronym

ESSENSE protocol for peri-operative patients management; a multi-center prospective clinical trial

Scientific Title

ESSENSE protocol for peri-operative patients management; a multi-center prospective clinical trial

Scientific Title:Acronym

ESSENSE protocol for peri-operative patients management; a multi-center prospective clinical trial

Region

Japan


Condition

Condition

Status after high-stress surgical procedure, such as esophagectomy, total or distal gastrectomy, colectomy, hepatectomy and pancreatico-duodenectomy.

Classification by specialty

Surgery in general Gastrointestinal surgery Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

ESSENSE protocol is extracted from Enhanced Recovery After Surgery (ERAS) protocol established in European society. The purpose of this study is to examine the effectiveness of ESSENSE protocol for the patients physical recovery after high-stress surgical treatment.
"ESSENSE" is an acronym of ESsential Strategy for Early Normalization after Surgery with patient's Excellent satisfaction.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II,III


Assessment

Primary outcomes

Post-operative patients recovery estimated by QoR40 format in 3rd and 7th postoperative days.

Key secondary outcomes

Patient's physical condition estimated by blood test; Albumin, total lymphocyte count, sodium, C-reactive protein and total cholesterol. Number of complications.
Length of hospital stay after surgery.


Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Patients in the study group will be managed by ESSENSE protocol as indicated below for 6 months. Control group will be managed by standard care protocol in each hospital.
1. Intensive pain control: postoperative pain will be estimated by Prince Henry Hospital pain scale and pain must be reduced to be able enough to cough.
2. Minimization of fasting: 400ml clear fluid will be provided until 2hour before induction of anesthesia and restart drinking since 1st postoperative day. Amount of intake is recorded in ESSENSE diary by medical staff and patients themselves.
3. Early mobilization: walking around the bed is scheduled since 1st postoperative day. Count of steps walking is recorded in ESSENSE diary by patients.
4. Encourage the will of recovery: Physical condition will be conscious by recording ESSENSE diary that is a tool for sharing the goal and the process of recovery among medical staff and patients themselves.

Interventions/Control_2

In contrast of ESSENSE protocol, control group patients will be managed by standard protocol. Pain killer will be administrated according to patient's complaints. Fasting in the day of the operation and restart drinking according to patient's bowel condition. Mobilization will be done voluntary.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who are judged as operable in the individual hospital.

Key exclusion criteria

1.Patients unable to record their physical status in diary.
2.Patients unable to drink from before an operation.
3.Patients unable to walk from before an operation.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Go Miyata

Organization

Tohoku University, Graduate School of Medicine

Division name

Division of Advanced Surgical Science and Technology

Zip code


Address

Seiryo-machi 1-1, Aoba-ku, Sendai,city, Miyagi pref. JAPAN

TEL

+81-22-717-7214

Email

miyata5@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Go Miyata

Organization

Japanese Society for Surgical metabolism and nutrition

Division name

Peri-operative management study group

Zip code


Address

Shunkosha Co.Ltd. Ohkubo 2-4-12, Shinjuku-ku, Tokyo, JAPAN

TEL

+81-3-5291-6231

Homepage URL

http://www.jsmmn.jp/essense/index.html

Email

essense@shunkosha.com


Sponsor or person

Institute

Japanese Society for Surgical metabolism and nutrition

Institute

Department

Personal name



Funding Source

Organization

Japanese Society for Surgical metabolism and nutrition

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院(宮城県)、浜松医療センター(静岡県)、下関医療センター(山口県)、埼玉医大国際医療センター(埼玉県)、小張総合病院(千葉県)、東邦大学医療センター大森病院(東京都)、関西医科大学(大阪府)、那須赤十字病院(栃木県)、横浜中央病院(神奈川県)、県立広島病院(広島県)、市立堺病院(大阪府)、東京慈恵会医科大学付属病院(東京都)、市立池田病院(大阪府)


Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 15 Day


Related information

URL releasing protocol

http://www.jsmmn.jp/essense/index.html

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 06 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 06 Month 05 Day

Last modified on

2016 Year 06 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016510


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name